Revolution Medicines participates in Guggenheim and Jefferies healthcare conferences
RVMD•Revolution Medicines CEO and Chairman Mark A. Goldsmith will participate in two investor conferences in November 2026. The conferences are scheduled for Nov. 10 and Nov. 16.
1. Conference appearances
Goldsmith will take part in a fireside chat at the 3rd Annual Guggenheim Healthcare Innovation Conference on Nov. 10, 2026, at 8:30 a.m. ET. He is also scheduled to participate in a fireside chat at the Jefferies Global Healthcare Conference in London on Nov. 16 at 5:30 a.m. ET.




